Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Prostaglandins Leukot Essent Fatty Acids. 2010 Apr-Jun;82(4-6):259-64. doi: 10.1016/j.plefa.2010.02.014. Epub 2010 Mar 3.
Cardiovascular disease (CVD) risk and rate of progression is determined by genetic, environmental and behavioural factors. Majority of genotype-diet-CVD phenotype research till date has focussed on the interactive impact of single nucleotide polymorphisms (SNP) and dietary fat composition, on blood lipids levels, with strong evidence of the existence of hypo- and hyper-responders. However, a recognised concern in the field of nutrigenetics is a lack of consistency between findings of different studies. This apparent lack of consistency is likely to be attributable to the impact of factors such as ethnicity and gender on the 'size' of nutrigenetic interactions, a clear understanding of which needs to be gained. Although not yet ready for widespread use, in the future a greater use of genetic profiling is likely to enhance current strategies of CVD prediction, and improve the design of more personalised approaches to minimise risk in the individual.
心血管疾病 (CVD) 的风险和进展速度由遗传、环境和行为因素决定。迄今为止,大多数基因型-饮食-CVD 表型研究都集中在单核苷酸多态性 (SNP) 和饮食脂肪组成对血液脂质水平的相互影响上,有强有力的证据表明存在低反应者和高反应者。然而,营养遗传学领域的一个公认关注点是,不同研究的发现之间缺乏一致性。这种明显的不一致性可能归因于种族和性别等因素对营养遗传相互作用“大小”的影响,需要对此有清晰的认识。虽然尚未准备好广泛使用,但未来对基因谱的更多利用可能会增强当前 CVD 预测策略,并改进更个性化方法的设计,以最大限度地降低个体风险。